{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T03:59:11Z","timestamp":1788667151554,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jcf.2020.02.014","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T18:42:08Z","timestamp":1583433728000},"page":"271-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Ebselen attenuates tobramycin-induced ototoxicity in mice"],"prefix":"10.1016","volume":"20","author":[{"given":"Rende","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J","family":"Longenecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Homan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2020.02.014_bib0001","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis fulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"AM J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2020.02.014_bib0002","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fncel.2017.00308","article-title":"Aminoglycoside-induced cochleotoxicity: a review","volume":"11","author":"Jiang","year":"2017","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"10.1016\/j.jcf.2020.02.014_bib0003","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00003446-199912000-00005","article-title":"An individualized, sensitive frequency range for early detection of ototoxicity","volume":"20","author":"Fausti","year":"1999","journal-title":"Ear Hear"},{"key":"10.1016\/j.jcf.2020.02.014_bib0004","unstructured":"(ASHA) American speech-language-hearing association. audiologic management of individuals receiving cochleotoxic drug therapy. [Guidelines]. Available from www.asha.org\/policy; 1994."},{"issue":"937861","key":"10.1016\/j.jcf.2020.02.014_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/937861","article-title":"Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection","volume":"2011","author":"Huth","year":"2011","journal-title":"Int J Otolaryngol"},{"issue":"1\u20132","key":"10.1016\/j.jcf.2020.02.014_bib0006","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.heares.2011.05.008","article-title":"New developments in aminoglycoside therapy and ototoxicity","volume":"281","author":"Xie","year":"2011","journal-title":"Hear Res"},{"key":"10.1016\/j.jcf.2020.02.014_bib0007","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1034\/j.1600-079x.2000.280104.x","article-title":"Ototoxicity caused by aminoglycosides is ameliorated by melatonin without interfering with the antibiotic capacity of the drugs","volume":"28","author":"Lopez\u2010Gonzalez","year":"2000","journal-title":"J Pineal Res"},{"issue":"1","key":"10.1016\/j.jcf.2020.02.014_bib0008","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/00016480802008199","article-title":"Protective effect of edaravone against tobramycin induced ototoxicity","volume":"129","author":"Asplund","year":"2009","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.jcf.2020.02.014_bib0009","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jcf.2015.06.005","article-title":"D-methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models","volume":"15","author":"Fox","year":"2016","journal-title":"J Cyst Fibros"},{"issue":"106","key":"10.1016\/j.jcf.2020.02.014_bib0010","article-title":"The contribution of immune infiltrates to ototoxicity and cochlear hair cell loss","volume":"11","author":"Wood","year":"2017","journal-title":"Front Cell Neurosci"},{"issue":"sup4","key":"10.1016\/j.jcf.2020.02.014_bib0011","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1080\/14992027.2018.1455114","article-title":"Protection for medication-induced hearing loss: the state of the science","volume":"57","author":"Hammill","year":"2018","journal-title":"Int J Audiol"},{"issue":"19","key":"10.1016\/j.jcf.2020.02.014_bib0012","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S1359-6446(05)03561-0","article-title":"Compounds for the prevention and treatment of noise-induced hearing loss","volume":"10","author":"Lynch","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jcf.2020.02.014_bib0013","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1097\/00005537-199911000-00003","article-title":"Application of antioxdiants and other agents to prevent cisplatin ototoxicity","volume":"109","author":"Rybak","year":"1999","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jcf.2020.02.014_bib0014","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.heares.2009.03.003","article-title":"Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells","volume":"251","author":"Kim","year":"2009","journal-title":"Hear Res"},{"key":"10.1016\/j.jcf.2020.02.014_bib0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.heares.2006.08.006","article-title":"Ebselen treatment reduces noise induced hearing loss via the mimicry and induction of glutathione peroxidase","volume":"226","author":"Kil","year":"2007","journal-title":"Hear Res"},{"issue":"10098","key":"10.1016\/j.jcf.2020.02.014_bib0016","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(17)31791-9","article-title":"Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"390","author":"Kil","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jcf.2020.02.014_bib0017","article-title":"The role of glia in the peripheral and central auditory system following noise overexposure: contribution of TNF-\u03b1 and IL-1\u03b2 to the pathogenesis of hearing loss","volume":"11","author":"Fuentes-Santamaria","year":"2017","journal-title":"Front Neuroanat"},{"key":"10.1016\/j.jcf.2020.02.014_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5955(01)00224-6","article-title":"Differential vulnerability of the basal and apical hair cells is based on intrinsic susceptibility to free radicals","volume":"155","author":"Sha","year":"2001","journal-title":"Hear Res"},{"issue":"0","key":"10.1016\/j.jcf.2020.02.014_bib0019","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.heares.2010.10.011","article-title":"Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea","volume":"272","author":"Hirose","year":"2011","journal-title":"Hear Res"},{"issue":"1\u20132","key":"10.1016\/j.jcf.2020.02.014_bib0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.heares.2007.12.002","article-title":"Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic cultures","volume":"236","author":"Qi","year":"2008","journal-title":"Hear Res"},{"issue":"12","key":"10.1016\/j.jcf.2020.02.014_bib0021","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1007\/s00405-014-2957-y","article-title":"Effect of intratympanic dimethyl sulphoxide (DMSO) in an in vivo model of cisplatin-related ototoxicity","volume":"271","author":"Rold\u00e1n-Fidalgo","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1\u20132","key":"10.1016\/j.jcf.2020.02.014_bib0022","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0378-5955(97)00191-3","article-title":"Loss of spiral ganglion cells as primary manifestation of aminoglycoside ototoxicity","volume":"115","author":"Sone","year":"1998","journal-title":"Hear Res"},{"key":"10.1016\/j.jcf.2020.02.014_bib0023","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.heares.2015.02.009","article-title":"Synaptopathy in the noise-exposed and aging cochlea: primary neural degermation in acquired sensorineural hearing loss","volume":"330","author":"Kujawa","year":"2015","journal-title":"Hear Res"},{"issue":"298","key":"10.1016\/j.jcf.2020.02.014_bib0024","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac5546","article-title":"Endotoxemia-mediated inflammation potentiates aminoglycoside-induced ototoxicity","volume":"7","author":"Koo","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcf.2020.02.014_bib0025","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10162-014-0476-6","article-title":"Systemic lipopolysaccharide compromises the blood-labyrinth barrier and increases entry of serum fluorescein into the perilymph","volume":"15","author":"Hirose","year":"2014","journal-title":"JARO"},{"issue":"1654","key":"10.1016\/j.jcf.2020.02.014_bib0026","article-title":"Cisplatin is retained in the cochlea indefinitely following chemotherapy","volume":"8","author":"Breglio","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2020.02.014_bib0027","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1172\/JCI118253","article-title":"A mouse model for the \u2206F508 allele of cystic fibrosis","volume":"96","author":"Zeiher","year":"1995","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.jcf.2020.02.014_bib0028","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data","volume":"14","author":"Van Boeckel","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.jcf.2020.02.014_bib0029","first-page":"1","article-title":"Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up","volume":"7","author":"Duggal","year":"2007","journal-title":"BMC Ear Nose Throat Disord"},{"key":"10.1016\/j.jcf.2020.02.014_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.heares.2004.08.002","article-title":"Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen","volume":"201","author":"Lynch","year":"2005","journal-title":"Hearing Research"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199320300631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199320300631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:43:51Z","timestamp":1761601431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199320300631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1569199320300631"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2020.02.014","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ebselen attenuates tobramycin-induced ototoxicity in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2020.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}